便Let-7b和miR-21直接调节肠道微生物群,导致慢性炎症
Maite Casado-Bedmar1, Maryline Roy1, Louis Berthet1
1Center for Research on Inflammation, Université Paris Cité, Paris, France.
Gut microbes
|September 3, 2024
概括
便中的microRNAs (miRNAs),let-7b和miR-21,在炎症性肠病 (IBD) 中促进炎症和失生症. 抑制这些miRNAs可以改善肠道屏障功能,并提供对结肠炎的保护.
科学领域:
- 胃肠病学 胃肠病学
- 微生物学 微生物学
- 分子生物学分子生物学
背景情况:
- 炎症性肠道疾病 (IBD) 的原因复杂,便微RNAs (miRNAs) 在肠道炎症和微生物群相互作用中的作用尚未完全理解.
- 便中的miRNAs与慢性炎症有关,但它们对IBD病原体的具体贡献需要进一步调查.
研究的目的:
- 调查便中let-7b和miR-21在IBD病变发生过程中的作用.
- 确定这些miRNAs如何影响肠道微生物群和宿主免疫反应.
- 在结肠炎模型中评估抑制let-7b和miR-21的治疗潜力.
主要方法:
- 在IBD患者和IL-10-/-小鼠中分析便中let-7b和miR-21水平.
- 在体外微生物群建模以评估miRNA对微生物组成和功能的影响.
- 在小鼠体内研究以评估光线miRNA增加和抑制对肠道炎症,屏障功能和宿主微生物群相互作用的影响.
主要成果:
- 在IBD患者和小鼠中,便中升高的let-7b和miR-21与炎症和特定细菌相关.
- let-7b和miR-21直接改变了微生物群的组成,增加了其促炎的潜力.
- 发光-7b增加了促炎性细胞因子,而miR-21损害了肠道屏障功能并诱导了功能失调.
- 在体内抑制let-7b和miR-21改善了肠道屏障功能,促进了更健康的宿主微生物群相互作用,并保护了结肠炎.
结论:
- 便中的miRNAs,特别是let-7b和miR-21,在宿主-微生物群通信中发挥着功能性作用.
- 这些miRNAs有助于IBD的肠道炎症和失生症.
- 用抗miRNA向便miRNAs是IBD和相关疾病的有前途的治疗策略.
关键词:
抗miR-21-21的使用方法.反-让-7b的反-让-7b的大肠炎是一种大肠炎.这种疾病叫做dysbiosis.胃肠道的微生物群主体-微生物群的相互作用.肠道的通透性 肠道的通透性让-7b成为-7b.这就是为什么miR-21这是一个微型RNA.更多相关视频
相关概念视频
01:17Irritable Bowel Syndrome I: Introduction
263
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
263
01:17Chronic Bowel Disorders: Introduction
414
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
414
01:30Inflammatory Bowel Disease II: Crohn's Disease
205
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
205
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
159
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
159
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
328
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
328
01:22MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K